VENOGLOBULIN Trademark

Trademark Overview


On Thursday, March 1, 2001, a trademark application was filed for VENOGLOBULIN with the United States Patent and Trademark Office. The USPTO has given the VENOGLOBULIN trademark a serial number of 76217836. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, December 26, 2009. This trademark is owned by Welfide Corporation. The VENOGLOBULIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the nature of gammaglobulin preparations for use in the treatment of primary immunodeficiencies, immune-mediated thrombocytopenia, Kawasaki syndrome, recent bone marrow transplant in adults, chronic B-cell lymphocytic leukemia, pediatric HIV infection, chronic inflammatory demyelinating polyneuropathy, post-transfusion purpura, Guillain-Barre syndrome and chronic inflammatory demyelinating polyneurophathy, anemia because of parvovirus B19, patients with stable multiple myeloma who are at high risk for recurrent infection, cytomegalovirus (CMV)-negative recipients of CMV-positive organs, hypogammaglobulinemic neonates with risk factor for infection or morbidity, intractable epilepsy, systemic vasculitic syndromes, warm-type automimmune hemolytic anemia, neonatal alloimmune thrombocytopenia when unresponsive to other treatments, immune-mediated neutropenia, decompensation in myasthenia gravis, dermatomyositis, polymyosits, thrombocytopenia when severe and u...
venoglobulin

General Information


Serial Number76217836
Word MarkVENOGLOBULIN
Filing DateThursday, March 1, 2001
Status710 - CANCELLED - SECTION 8
Status DateSaturday, December 26, 2009
Registration Number2717023
Registration DateTuesday, May 20, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 25, 2003

Trademark Statements


Goods and ServicesPharmaceutical preparations in the nature of gammaglobulin preparations for use in the treatment of primary immunodeficiencies, immune-mediated thrombocytopenia, Kawasaki syndrome, recent bone marrow transplant in adults, chronic B-cell lymphocytic leukemia, pediatric HIV infection, chronic inflammatory demyelinating polyneuropathy, post-transfusion purpura, Guillain-Barre syndrome and chronic inflammatory demyelinating polyneurophathy, anemia because of parvovirus B19, patients with stable multiple myeloma who are at high risk for recurrent infection, cytomegalovirus (CMV)-negative recipients of CMV-positive organs, hypogammaglobulinemic neonates with risk factor for infection or morbidity, intractable epilepsy, systemic vasculitic syndromes, warm-type automimmune hemolytic anemia, neonatal alloimmune thrombocytopenia when unresponsive to other treatments, immune-mediated neutropenia, decompensation in myasthenia gravis, dermatomyositis, polymyosits, thrombocytopenia when severe and unresponsive to other treatments

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, December 26, 2009
Primary Code005
First Use Anywhere DateThursday, February 26, 1987
First Use In Commerce DateThursday, February 26, 1987

Trademark Owner History


Party NameWelfide Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 541-0046
JP

Party NameWelfide Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 541-0046
JP

Party NameWelfide Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 541-0046
JP

Trademark Events


Event DateEvent Description
Saturday, December 26, 2009CANCELLED SEC. 8 (6-YR)
Friday, March 14, 2008CASE FILE IN TICRS
Tuesday, May 20, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, February 25, 2003PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2003NOTICE OF PUBLICATION
Tuesday, December 24, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 24, 2002USE AMENDMENT ACCEPTED
Thursday, June 27, 2002NON-FINAL ACTION MAILED
Thursday, June 6, 2002ASSIGNED TO EXAMINER
Monday, February 25, 2002ASSIGNED TO EXAMINER
Friday, November 16, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 2, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 28, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 28, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 29, 2001NON-FINAL ACTION MAILED
Monday, July 2, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 17, 2001AMENDMENT TO USE PROCESSING COMPLETE
Monday, July 2, 2001USE AMENDMENT FILED
Thursday, June 28, 2001NON-FINAL ACTION MAILED
Wednesday, June 27, 2001ASSIGNED TO EXAMINER